Sign in

Conni Ciavarella

@conniciavarella.bsky.social
108 followers 84 following 5 posts

Research fellow in mathematical modelling of infectious diseases, Montpellier University

PostsRepliesMedia
Reposted by Conni Ciavarella
IDDjobs @iddjobs.org · 12/06/2026
2 Postdocs (Montpellier, France) Malaria incidence and intervention modelling with @conniciavarella.bsky.social at University of Montpellier More details: iddjobs.org/jobs/2552
001
Reposted by Conni Ciavarella
Simon Cauchemez @scauchemez.bsky.social · 05/06/2025
New postdoc positions with a number of exciting epidemic modelling projects opening in our Unit at @pasteur.fr in beautiful Paris. Deadline for applications: 26th June. research.pasteur.fr/en/job/postd...
research.pasteur.fr
Postdoctoral positions in epidemic mathematical/statistical modelling - Research
Job description We are recruiting postdocs to contribute to research projects in the Mathematical Modelling of Infectious Diseases Unit, at Institut Pasteur in Paris. The candidates will be expected t...
05665
Conni Ciavarella @conniciavarella.bsky.social · 27/01/2025
In conclusion: - From a patient perspective, high-dose PQ and TQ is warranted - From a community perspective, low-dose and high-dose drug regimens will cause similar reductions in P. vivax transmission Ensuring high drug safety, adherence and coverage is key to maximising PQ and TQ impact.
020
Conni Ciavarella @conniciavarella.bsky.social · 27/01/2025
We quantified the community-level impact of routinely treating symptomatic P. vivax cases with PQ or TQ using an existing agent-based model. - All regimens can achieve a similar impact - Drug adherence and eligibility criteria hamper impact - Impact decreases with increasing transmission intensity
130
Conni Ciavarella @conniciavarella.bsky.social · 27/01/2025
We estimated the patient-level efficacy of PQ and TQ by calibrating a novel mathematical model to clinical trial data. - Effective treatment can eliminate almost all P. vivax hypnozoites - PQ and TQ regimens have differing efficacies
100
Conni Ciavarella @conniciavarella.bsky.social · 27/01/2025
Unlike the more common P. falciparum, P. vivax forms dormant liver stage parasites (hypnozoites) that can reactivate weeks to months after primary infection to cause recurrent infections. The efficacy of liver-stage drugs PQ and TQ cannot be estimated directly because hypnozoites are undetectable.
100
Conni Ciavarella @conniciavarella.bsky.social · 27/01/2025
New paper out in The Lancet Infectious Diseases! This paper answers questions around the efficacy of primaquine (PQ) and tafenoquine (TQ) against P. vivax malaria. www.thelancet.com/journals/lan...
thelancet.com
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics
Substantial reductions in prevalence as measured by PCR were predicted with primaquine and tafenoquine regimens if these could be implemented with high coverage and adherence. The benefits of preventi...
191
Reposted by Conni Ciavarella
IDDjobs @iddjobs.org · 24/01/2025
Postdoc (Montpellier, France) Mathematical modelling of Plasmodium vivax malaria with @conniciavarella.bsky.social at @umontpellier.bsky.social More details: iddjobs.org/jobs/2236
073
Reposted by Conni Ciavarella
IDDjobs @iddjobs.org · 24/01/2025
Postdoc (Montpellier, France) Mathematical/statistical modelling of respiratory virus transmission with @conniciavarella.bsky.social; @mtsofonea.bsky.social at @umontpellier.bsky.social More details: iddjobs.org/jobs/2237
084